• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重进行性多发性硬化症中的认知功能

Cognitive function in severe progressive multiple sclerosis.

作者信息

Jakimovski Dejan, Zivadinov Robert, Weinstock Zachary, Burnham Alex, Wicks Taylor R, Suchan Christopher, Sciortino Tommaso, Schweser Ferdinand, Bergsland Niels, Dwyer Michael G, Eckert Svetlana P, Young-Hong David, Weinstock-Guttman Bianca, Benedict Ralph H B

机构信息

Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA.

Center for Biomedical Imaging at the Clinical Translational Science Institute, University at Buffalo, State University of New York, Buffalo, NY 14203, USA.

出版信息

Brain Commun. 2024 Jul 2;6(4):fcae226. doi: 10.1093/braincomms/fcae226. eCollection 2024.

DOI:10.1093/braincomms/fcae226
PMID:39015768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11250210/
Abstract

Cognitive impairment is common in multiple sclerosis and negatively impacts quality of life. Cognitive status has yet to be described in people with severe progressive multiple sclerosis, in whom conventional neuropsychological testing is exceptionally difficult. The objective for the study was to characterize cognitive performance in severe progressive multiple sclerosis and compare them with age-, sex- and disease duration-matched less disabled people with multiple sclerosis using a specifically developed auditory, non-motor test of attention/cognitive processing speed-Auditory Test of Processing Speed. Also, we aimed to determine the relationship between cognitive performance and MRI-based outcomes in these matched cohorts. The Comprehensive Assessment of Severely Affected Multiple Sclerosis study was carried out at the University at Buffalo and the Boston Home, a skilled nursing facility in Dorchester, MA. Inclusion criteria were age 30-80 years and expanded disability status scale 3.0-6.5 for community-dwelling and 7.0-9.5 for skilled nursing facility people with multiple sclerosis. The cognitive assessment was performed using the Brief International Cognitive Assessment for Multiple Sclerosis consisting of Symbol Digit Modalities Test, Brief Visuospatial Memory Test-Revised, California Verbal Learning Test-2nd edition along with Auditory Test of Processing Speed, Paced Auditory Serial Addition Test-3 second and Controlled Oral Word Association Test. MRI scans were retrospectively collected and analysed for lesion and volumetric brain measurements. The rate of completion and performance of the cognitive tests was compared between the groups, and the relationship with MRI measures was determined using sex, age and years of education-adjusted linear regression models. Significantly greater percentage of the severe multiple sclerosis group completed Auditory Test of Processing Speed when compared with the current gold standard of Symbol Digit Modalities Test (93.2% versus 65.9%). Severe progressive multiple sclerosis had worse cognitive performance in all cognitive domains with greatest differences for cognitive processing speed (Symbol Digit Modalities Test > Paced Auditory Serial Addition Test-3 second > Auditory Test of Processing Speed, Cohen's < 2.13, < 0.001), learning and memory (Cohen's < 1.1, < 0.001) and language (Controlled Oral Word Association Test with Cohen's = 0.97, < 0.001). Multiple cognitive domains were significantly associated with lower thalamic (standardized β < 0.419, < 0.006) and cortical (standardized β < 0.26, < 0.031) volumes. Specially designed (auditory) cognitive processing speed tests may provide more sensitive screening of cognitive function in severe progressive multiple sclerosis. The cognitive profile of severe multiple sclerosis is proportional to their physical outcomes and best explained by decreased grey matter volume.

摘要

认知障碍在多发性硬化症中很常见,并且会对生活质量产生负面影响。严重进展型多发性硬化症患者的认知状况尚未得到描述,因为对他们进行传统的神经心理学测试异常困难。本研究的目的是通过专门开发的听觉、非运动性注意力/认知处理速度测试——听觉处理速度测试,来描述严重进展型多发性硬化症患者的认知表现,并将其与年龄、性别和病程匹配的残疾程度较轻的多发性硬化症患者进行比较。此外,我们旨在确定这些匹配队列中认知表现与基于磁共振成像(MRI)的结果之间的关系。“严重受影响的多发性硬化症综合评估”研究在布法罗大学和位于马萨诸塞州多切斯特的熟练护理机构波士顿之家进行。纳入标准为年龄30 - 80岁,社区居住的多发性硬化症患者扩展残疾状态量表评分为3.0 - 6.5,熟练护理机构的患者为7.0 - 9.5。认知评估使用了简短国际多发性硬化症认知评估,包括符号数字模式测试、修订版简短视觉空间记忆测试、加利福尼亚言语学习测试第二版以及听觉处理速度测试、3秒听觉连续加法测试和受控口语单词联想测试。MRI扫描是回顾性收集的,并对病变和脑容量进行分析。比较了两组认知测试的完成率和表现,并使用性别、年龄和受教育年限调整的线性回归模型确定与MRI测量结果的关系。与当前的符号数字模式测试这一黄金标准相比,严重多发性硬化症组完成听觉处理速度测试的比例显著更高(93.2%对65.9%)。严重进展型多发性硬化症在所有认知领域的认知表现都更差,在认知处理速度方面差异最大(符号数字模式测试>3秒听觉连续加法测试>听觉处理速度测试,科恩效应量<2.13,P<0.001)、学习和记忆方面(科恩效应量<1.1,P<0.001)以及语言方面(受控口语单词联想测试,科恩效应量 = 0.97,P<0.001)。多个认知领域与丘脑体积减小(标准化β<0.419,P<0.006)和皮质体积减小(标准化β<0.26,P<0.031)显著相关。专门设计的(听觉)认知处理速度测试可能会为严重进展型多发性硬化症的认知功能提供更敏感的筛查。严重多发性硬化症的认知概况与其身体状况成正比,并且灰质体积减少能最好地解释这一情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f285/11250210/8392db690cf8/fcae226f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f285/11250210/7ed0cdd9a3ca/fcae226_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f285/11250210/e51a304b1a23/fcae226f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f285/11250210/c7ae6f84b77c/fcae226f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f285/11250210/8392db690cf8/fcae226f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f285/11250210/7ed0cdd9a3ca/fcae226_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f285/11250210/e51a304b1a23/fcae226f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f285/11250210/c7ae6f84b77c/fcae226f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f285/11250210/8392db690cf8/fcae226f3.jpg

相似文献

1
Cognitive function in severe progressive multiple sclerosis.严重进行性多发性硬化症中的认知功能
Brain Commun. 2024 Jul 2;6(4):fcae226. doi: 10.1093/braincomms/fcae226. eCollection 2024.
2
Pharmacological treatment for memory disorder in multiple sclerosis.多发性硬化症记忆障碍的药物治疗。
Cochrane Database Syst Rev. 2013 Dec 17;2013(12):CD008876. doi: 10.1002/14651858.CD008876.pub3.
3
Cholinesterase inhibitors for rarer dementias associated with neurological conditions.用于治疗与神经疾病相关的罕见痴呆症的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2015 Mar 3;2015(3):CD009444. doi: 10.1002/14651858.CD009444.pub3.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
5
Azathioprine for people with multiple sclerosis.硫唑嘌呤用于多发性硬化症患者。
Cochrane Database Syst Rev. 2024 Dec 9;12(12):CD015005. doi: 10.1002/14651858.CD015005.pub2.
6
Information processing speed modulation by electrical brain stimulation in multiple sclerosis: towards individually tailored protocols.多发性硬化症中通过脑电刺激进行信息处理速度调节:迈向个性化定制方案
Brain Commun. 2025 Jun 6;7(3):fcaf223. doi: 10.1093/braincomms/fcaf223. eCollection 2025.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
The temporal dynamics and clinical relevance of choroid plexus measures in multiple sclerosis.多发性硬化症中脉络丛测量的时间动态变化及临床相关性
Brain Commun. 2025 Jun 14;7(3):fcaf239. doi: 10.1093/braincomms/fcaf239. eCollection 2025.

引用本文的文献

1
Cognitive impairment, mood, and fatigue in various multiple sclerosis subtypes: a one-year follow-up study.不同多发性硬化症亚型中的认知障碍、情绪和疲劳:一项为期一年的随访研究。
J Neurol. 2025 May 14;272(6):398. doi: 10.1007/s00415-025-13115-y.

本文引用的文献

1
Multiple sclerosis.多发性硬化症。
Lancet. 2024 Jan 13;403(10422):183-202. doi: 10.1016/S0140-6736(23)01473-3. Epub 2023 Nov 7.
2
Auditory Test of Processing Speed: Preliminary validation of a smartphone-based test of mental speed.听觉加工速度测试:基于智能手机的心理速度测试的初步验证。
Mult Scler. 2023 Nov;29(13):1646-1658. doi: 10.1177/13524585231199311. Epub 2023 Oct 16.
3
Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis: A Systematic Review.统一多发性硬化症中与复发活动无关的进展的定义:一项系统评价
JAMA Neurol. 2023 Nov 1;80(11):1232-1245. doi: 10.1001/jamaneurol.2023.3331.
4
Cortical thickness and cognition in older people with multiple sclerosis.老年多发性硬化症患者的皮质厚度与认知功能
J Neurol. 2023 Nov;270(11):5223-5234. doi: 10.1007/s00415-023-11945-2. Epub 2023 Aug 27.
5
Making Visible the Invisible: Automatically Measured Global and Regional Brain Volume Is Associated with Cognitive Impairment and Fatigue in Multiple Sclerosis.让不可见变为可见:自动测量的全脑和局部脑容量与多发性硬化症中的认知障碍和疲劳相关。
Bioengineering (Basel). 2022 Dec 29;10(1):41. doi: 10.3390/bioengineering10010041.
6
A proposed new taxonomy of cognitive phenotypes in multiple sclerosis: The International Classification of Cognitive Disorders in MS (IC-CoDiMS).多发性硬化症认知表型的一种新分类法提议:《多发性硬化症认知障碍国际分类》(IC-CoDiMS)。
Mult Scler. 2023 Apr;29(4-5):615-627. doi: 10.1177/13524585221127941. Epub 2022 Oct 14.
7
How do patients with secondary progressive multiple sclerosis enrolled in the EXPAND randomized controlled trial compare with those seen in German clinical practice in the NeuroTransData multiple sclerosis registry?参与EXPAND随机对照试验的继发进展型多发性硬化症患者与神经转导数据多发性硬化症登记处德国临床实践中的患者相比情况如何?
J Cent Nerv Syst Dis. 2022 Aug 4;14:11795735221115912. doi: 10.1177/11795735221115912. eCollection 2022.
8
Multisite MRI reproducibility of lateral ventricular volume using the NAIMS cooperative pilot dataset.使用 NAIMS 合作试点数据集评估侧脑室容积的多中心 MRI 可重复性。
J Neuroimaging. 2022 Sep;32(5):910-919. doi: 10.1111/jon.12998. Epub 2022 Apr 5.
9
Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRI.仅使用临床常规 T2-FLAIR MRI 对多发性硬化症进行疾病病理量化和预测疾病进展。
Neuroimage Clin. 2021;31:102705. doi: 10.1016/j.nicl.2021.102705. Epub 2021 May 24.
10
The Symbol Digit Modalities Test (SDMT) is sensitive but non-specific in MS: Lexical access speed, memory, and information processing speed independently contribute to SDMT performance.符号数字模式测试(SDMT)在多发性硬化症中具有敏感性但缺乏特异性:词汇访问速度、记忆和信息处理速度均独立影响 SDMT 的表现。
Mult Scler Relat Disord. 2021 Jun;51:102950. doi: 10.1016/j.msard.2021.102950. Epub 2021 Apr 11.